Labcorp Expands PathAI Pact to Roll Out Digital Pathology Platform in US
Labcorp announced an expanded partnership with PathAI to deploy the AISight Dx digital pathology platform across its U.S. anatomic pathology labs and hospital sites. The AI‑enabled software will allow pathologists to scan, annotate and diagnose slides digitally, aiming to cut turnaround times and improve consistency. PathAI’s platform, cleared by the FDA in 2022 and updated under a 2025 510(k) clearance, supports secure storage, image analysis and workflow integration. The move follows Quest Diagnostics’ 2024 licensing of the same technology and reflects a broader industry shift toward AI‑driven diagnostics.
Guardant Buys MetaSight for $59M Upfront to Acquire Blood Test Tech
Guardant Health has agreed to acquire Israel‑based MetaSight Diagnostics for $59 million in cash, with up to $90 million in performance‑based earn‑outs. MetaSight brings mass‑spectrometry‑driven multi‑omics liquid‑biopsy technology, targeting colorectal cancer, liver fibrosis, myocardial infarction, and diabetic kidney disease. The deal broadens...
Transforming Epilepsy Care: How Innovative Implantable Neurotechnology Offers New Hope
PRECISIS GmbH’s EASEE® epicranial neurostimulation system offers a minimally invasive alternative for drug‑resistant focal epilepsy. The implant, positioned under the scalp atop the skull, delivers targeted electrical pulses without opening the skull, achieving a median 68% seizure reduction over two...
Senseonics Launches Automated Insulin Dosing System with 1-Year CGM
Senseonics and Sequel Med Tech have launched an automated insulin‑delivery system that pairs the year‑long Eversense 365 implantable CGM with Sequel’s twiist pump. The integration, delayed to Q4 2025, marks the first AID solution using a one‑year sensor, contrasting with competitors’ 15‑day...
FDA Issues Early Alert on Trividia Glucometer Issue Linked to 114 Injuries
The FDA issued an early alert after linking Trividia Health’s True Metrix glucometers to 114 injuries and one death. The alert cites an E‑5 error code that appears when blood glucose exceeds 600 mg/dL or when a test‑strip fault occurs, potentially...
Medline Addresses Bed Fire Risk Linked to Death
Medline is revising usage instructions for its home‑care adjustable beds after the FDA documented safety incidents involving hand‑control pendants that sparked, melted or ignited, and entrapment hazards from third‑party accessories. The agency recorded 12 injuries and two deaths—one fire‑related and...
Medtronic Completes First Hugo Case in the US
Medtronic performed the first U.S. Hugo robotic surgery—a prostatectomy at the Cleveland Clinic—shortly after receiving FDA clearance. The system, already CE‑marked in Europe, is being installed at Duke University Hospital and Atrium Health, marking its initial U.S. footprint. CEO Geoff...
Dexcom Seeks Expanded Medicare Coverage of CGMs for Type 2 Diabetes
Dexcom is lobbying the Centers for Medicare & Medicaid Services for expanded coverage of its continuous glucose monitors (CGMs) for Type 2 diabetes patients who do not use insulin. The company estimates the change could make CGMs available to roughly 12 million...
Siemens Healthineers, Mayo Clinic Partner on Neurodegenerative Disease, Cancer
Siemens Healthineers and Mayo Clinic have expanded their strategic partnership to accelerate AI‑driven imaging and interventional technologies for neurodegenerative disease, prostate cancer, and metastatic liver tumors. The agreement emphasizes AI‑enabled ultra‑high‑field MRI protocols for Alzheimer’s detection, AI tools to reduce...
Novocure Wins FDA Approval to Treat Pancreatic Cancer with Electric Fields
Novocure received FDA clearance for its Optune Pax tumor‑treating‑field device in locally advanced pancreatic cancer, marking the company’s first indication beyond brain tumors. The pivotal trial of 571 patients showed a statistically significant two‑month overall‑survival gain (16.2 vs 14.2 months) when the device was...
Neurent Raises $74M to Commercialize Treatment for Nasal Condition
Neurent Medical announced a €62.5 million ($74 million) Series C round to accelerate commercialization of its Neuromark radio‑frequency device for chronic rhinitis. The FDA has cleared the latest version of Neuromark, which delivers low‑power energy to disrupt nasal nerve signals and has demonstrated...
Zimmer Plans US Salesforce Reorganization
Zimmer Biomet announced a U.S. salesforce reorganization aimed at creating a fully dedicated, product‑specialized team of 2,500 reps. The shift targets high‑growth segments such as sports medicine, trauma, robotics, and ambulatory surgery centers, with one‑third of the transition already complete....
Baxter Cuts Roughly 90 Jobs at IV Solutions Plant that Recovered From Hurricane Helene
Baxter International announced it is cutting roughly 90 positions at its Marion, North Carolina IV solutions plant, representing about 3% of the site’s workforce. The facility, which supplies roughly 60% of U.S. IV fluids, recovered from Hurricane Helene damage but...